• Sun. Oct 25th, 2020

Dimancherouge

Technology

Endocrinology

  • Home
  • Sojournix Announces Publication of Results from SJX-653 Proof-of-Mechanism Study in The Journal of Clinical Endocrinology & Metabolism

Sojournix Announces Publication of Results from SJX-653 Proof-of-Mechanism Study in The Journal of Clinical Endocrinology & Metabolism

– Novel, Potent, Selective NK3 Antagonist in Phase 2 Clinical Development for Menopausal Hot Flashes – – Statistically Significant Effect on Pharmacodynamic Markers of NK3 Receptor Antagonism and Once-Daily (QD)…